Young-onset colorectal cancer

MCW Spaander, AG Zauber, S Syngal… - Nature reviews Disease …, 2023 - nature.com
In the past decades the incidence of colorectal cancer (CRC) in people under the age of 50
years has increased, which is referred to as early-onset CRC or young-onset CRC (YO …

Liver metastases

DI Tsilimigras, P Brodt, PA Clavien… - Nature reviews Disease …, 2021 - nature.com
Liver metastases are commonly detected in a range of malignancies including colorectal
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer

J Tie, JD Cohen, K Lahouel, SN Lo… - … England Journal of …, 2022 - Mass Medical Soc
Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …

The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer

JD Vogel, SI Felder, AR Bhama… - Diseases of the Colon …, 2022 - journals.lww.com
METHODS This guideline is based on the previous colon cancer parameter published in
2017. 10 Compared with 2017, this guideline has 11 new, 10 updated, and 2 excluded …

Pathological features and prognostication in colorectal cancer

K Chen, G Collins, H Wang, JWT Toh - Current Oncology, 2021 - mdpi.com
The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined
by the Union for International Cancer Control (UICC) and American Joint Committee on …

Treatment of patients with late-stage colorectal cancer: ASCO resource-stratified guideline

EG Chiorean, G Nandakumar, T Fadelu… - JCO Global …, 2020 - ascopubs.org
PURPOSE To provide expert guidance to clinicians and policymakers in resource-
constrained settings on the management of patients with late-stage colorectal cancer …

[HTML][HTML] Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions

S Chakrabarti, CY Peterson, D Sriram… - World journal of …, 2020 - ncbi.nlm.nih.gov
Colon cancer continues to be one of the leading causes of mortality and morbidity
throughout the world despite the availability of reliable screening tools and effective …

[HTML][HTML] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer

T Yoshino, G Argilés, E Oki, E Martinelli, H Taniguchi… - Annals of …, 2021 - Elsevier
Highlights•This article provides ESMO expert recommendations adapted for the treatment of
localised colon cancer in Asian patients.•The aim was to provide guidance for the …

The role of p53 dysfunction in colorectal cancer and its implication for therapy

M Michel, L Kaps, A Maderer, PR Galle, M Moehler - Cancers, 2021 - mdpi.com
Simple Summary Despite remarkable progress being made by preventive medical check-
ups in the last decades, colorectal cancer (CRC) remains one of the most frequent and …

[HTML][HTML] Colon cancer

G Menon, A Recio-Boiles, S Lotfollahzadeh… - StatPearls …, 2024 - ncbi.nlm.nih.gov
Objectives: Screen individuals at risk of colon cancer. Create a clinically appropriate
diagnostic plan for people with possible colorectal cancer. Develop a personalized …